Yifan Pharmaceutical Co., Ltd.
Shenzhen Stock Exchange 002019.SZ
Yifan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2023: USD -77.62 M
-
Yifan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2022 was USD 18.43 M, a -57.95% change year over year.
-
Yifan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2021 was USD 43.81 M, a -70.47% change year over year.
-
Yifan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2020 was USD 148.36 M, a 14.35% change year over year.
-
Yifan Pharmaceutical Co., Ltd. Net Income for the year ending December 31, 2019 was USD 129.74 M, a 21.00% change year over year.
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Net Income Margin |
|---|
| CEO | Mr. Xian Feng Cheng |
| IPO Date | July 13, 2004 |
| Location | China |
| Headquarters | No. 50, Qinshan |
| Employees | 4,230 |
| Sector | Health Care |
| Industries | |
Yifan Pharmaceutical Co., Ltd. produces and sells drugs and medicines in China and internationally. It provides drugs across gynecology, pediatrics, orthopedics, and dermatology therapeutic areas; therapeutic infusion solutions; and pantothenic acid and Provitamin B5 products. The company also provides Chinese traditional medicines, women's health products, and blood tumor drugs. In addition, it offers APIs, including feed additives/animal health products, skin and hair care ingredients, functional food additives, and fine chemicals; and PBAT/PBS biodegradable resins and PVB films. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is based in Hangzhou, China.
Past 5 years
USD 0.79
USD 1.04
USD 2.97
USD 5.92
USD 2.17
StockViz Staff
January 15, 2025
Any question? Send us an email